JP Morgan Chase
SEM

JP Morgan Chase’s Select Medical SEM Stock Holding History

JP Morgan Chase’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Sell
191,396
-99,242
-34% -$1.64M ﹤0.01% 3821
2026
Q1 		$4.73M Buy
290,638
+69,068
+31% +$1.08M ﹤0.01% 3363
2025
Q4 		$3.29M Sell
221,570
-332,633
-60% -$4.7M ﹤0.01% 3687
2025
Q3 		$7.12M Buy
554,203
+109,788
+25% +$1.46M ﹤0.01% 3037
2025
Q2 		$6.75M Buy
444,415
+86,343
+24% +$1.35M ﹤0.01% 2881
2025
Q1 		$5.98M Sell
358,072
-134,311
-27% -$2.47M ﹤0.01% 3001
2024
Q4 		$9.28M Sell
492,383
-280,268
-36% -$5.4M ﹤0.01% 2759
2024
Q3 		$14.5M Buy
772,651
+68,496
+10% +$1.31M ﹤0.01% 2286
2024
Q2 		$13.3M Sell
704,155
-14,850
-2% -$253K ﹤0.01% 2200
2024
Q1 		$11.7M Buy
719,005
+69,128
+11% +$1.01M ﹤0.01% 2347
2023
Q4 		$8.23M Buy
649,877
+127,064
+24% +$1.6M ﹤0.01% 2648
2023
Q3 		$7.12M Sell
522,813
-21,750
-4% -$336K ﹤0.01% 2565
2023
Q2 		$9.35M Buy
544,563
+23,747
+5% +$368K ﹤0.01% 2339
2023
Q1 		$7.25M Buy
520,816
+211,705
+68% +$3.12M ﹤0.01% 2541
2022
Q4 		$4.14M Buy
309,111
+25,702
+9% +$332K ﹤0.01% 2986
2022
Q3 		$3.38M Sell
283,409
-367,999
-56% -$5.23M ﹤0.01% 3059
2022
Q2 		$8.29M Sell
651,408
-163,836
-20% -$2.1M ﹤0.01% 2321
2022
Q1 		$10.5M Sell
815,244
-160,784
-16% -$2.12M ﹤0.01% 2316
2021
Q4 		$15.5M Buy
976,028
+178
+0% +$3.04K ﹤0.01% 2052
2021
Q3 		$19M Sell
975,850
-85,407
-8% -$1.7M ﹤0.01% 1808
2021
Q2 		$24.2M Sell
1,061,257
-309,080
-23% -$6.41M ﹤0.01% 1682
2021
Q1 		$25.2M Buy
1,370,337
+223,171
+19% +$3.66M ﹤0.01% 1561
2020
Q4 		$17.1M Sell
1,147,166
-67,996
-6% -$887K ﹤0.01% 1753
2020
Q3 		$13M Sell
1,215,162
-137,342
-10% -$1.35M ﹤0.01% 1828
2020
Q2 		$10.7M Buy
1,352,504
+214,217
+19% +$1.77M ﹤0.01% 1844
2020
Q1 		$9.2M Buy
1,138,287
+314,947
+38% +$3.74M ﹤0.01% 1816
2019
Q4 		$10.4M Buy
823,340
+38,813
+5% +$418K ﹤0.01% 2085
2019
Q3 		$7M Buy
784,527
+527,913
+206% +$4.61M ﹤0.01% 2410
2019
Q2 		$2.17M Sell
256,614
-8,428
-3% -$66.6K ﹤0.01% 3328
2019
Q1 		$2.01M Sell
265,042
-184,678
-41% -$1.48M ﹤0.01% 3323
2018
Q4 		$3.72M Sell
449,720
-80,355
-15% -$769K ﹤0.01% 2805
2018
Q3 		$5.25M Sell
530,075
-469,529
-47% -$4.86M ﹤0.01% 2704
2018
Q2 		$9.78M Sell
999,604
-219,955
-18% -$2.16M ﹤0.01% 2163
2018
Q1 		$11.3M Buy
1,219,559
+210,567
+21% +$2M ﹤0.01% 1934
2017
Q4 		$9.6M Sell
1,008,992
-15,659
-2% -$150K ﹤0.01% 2159
2017
Q3 		$10.4M Buy
1,024,651
+202,785
+25% +$1.87M ﹤0.01% 1951
2017
Q2 		$6.8M Sell
821,866
-50,669
-6% -$380K ﹤0.01% 2259
2017
Q1 		$6.28M Buy
872,535
+278,836
+47% +$2.02M ﹤0.01% 2274
2016
Q4 		$4.24M Buy
593,699
+471,324
+385% +$3.28M ﹤0.01% 2588
2016
Q3 		$890K Buy
122,375
+116,985
+2,170% +$744K ﹤0.01% 3187
2016
Q2 		$32K Buy
5,390
+425
+9% +$2.82K ﹤0.01% 4137
2016
Q1 		$32K Sell
4,965
-10,664
-68% -$57.2K ﹤0.01% 3996
2015
Q4 		$101K Sell
15,629
-344,203
-96% -$2.15M ﹤0.01% 3783
2015
Q3 		$2.09M Sell
359,832
-432,480
-55% -$3.21M ﹤0.01% 2720
2015
Q2 		$6.92M Buy
+792,312
New +$6.65M ﹤0.01% 2178
2015
Q1 		– Sell
-395,666
Closed -$3.07M – 4248
2014
Q4 		$3.07M Buy
395,666
+170,568
+76% +$1.24M ﹤0.01% 2715
2014
Q3 		$1.46M Sell
225,098
-269,856
-55% -$2.08M ﹤0.01% 3124
2014
Q2 		$4.16M Buy
494,954
+372,465
+304% +$2.89M ﹤0.01% 2158
2014
Q1 		$822K Buy
122,489
+39,906
+48% +$242K ﹤0.01% 2930
2013
Q4 		$517K Sell
82,583
-252,284
-75% -$1.23M ﹤0.01% 3475
2013
Q3 		$1.46M Sell
334,867
-20,607
-6% -$94.2K ﹤0.01% 3017
2013
Q2 		$1.57M Buy
+355,474
New +$1.57M ﹤0.01% 2963

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

JP Morgan Chase's SEM Position: Q2 2026 in Review

JP Morgan Chase reduced its Select Medical (SEM) stake by 34% in Q2 2026, selling an estimated $1.64M and leaving 191,396 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3821.

JP Morgan Chase first reported a position in SEM in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.2M in Q1 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • JP Morgan Chase held 191,396 shares of Select Medical worth $3.24M as of Q2 2026.
  • JP Morgan Chase sold 99,242 Select Medical shares in Q2 2026, an estimated $1.64M.
  • Select Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3821 holding.
  • JP Morgan Chase first reported a position in Select Medical in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Select Medical position peaked at $25.2M in Q1 2021.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.